Skip to main content
Filing year 2023

VAN ANDEL RESEARCH INSTITUTE

Grand Rapids, Michigan·EIN 52-2000823·NTEE H300 · Medical Research·3
Total revenue
$112.7M
Total assets
$190.5M
Total expenses
$0
Reported officers
16
Mission

MEDICAL RESEARCH ORGANIZATION VAN ANDEL RESEARCH INSTITUTE IS AN INDEPENDENT BIOMEDICAL RESEARCH ORGANIZATION COMMITTED TO IMPROVING THE HEALTH AND ENHANCING THE LIVES OF CURRENT AND FUTURE GENERATIONS.

Executive compensation, broken down

Form 990 · Schedule J · 15 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Chief Investment Officer
highest compensated employee
$1.7M
Assoc Direct-sr. Portfolio Mgr.
highest compensated employee
$1.2M
Chief Scientific Officer & Res. Dir.
key employee
$1.1M
Senior Portfolio Manager
highest compensated employee
$844k
Chairman / CEO
board chair
$800k
Chief Operat. Officer (end 4/1/2024)
officer (unspecified)
$737k
General Counsel
key employee
$613k
Chief Strat. Officer (end 7/5/2024)
key employee
$603k
Vice President & Cao/cfo
vice president
$586k
Distinguished Investigator
highest compensated employee
$576k
Sr. Scientific Investigator & Dept. Chair
board chair
$506k
Trustee
board member
$10k
Trustee
board member
$10k
Trustee
board member
$8k
Trustee
board member
$7k

Plus 1 unpaid individual.

Browse compensation in Medical Research

Up 9%
from 2022

From $1.6M in 2022 to $1.7M in 2023.

$1.6M
2022
$1.7M
2023
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.